Stock report · Delisted · Nasdaq
Aspira Womens Health Inc (AWH)
0.03USD Delisted Final close · Apr 17, 2025
AWH no longer trades. Aspira Womens Health was delisted from the Nasdaq in April 2025.
All prices on this page are historical. The last trade was on April 17, 2025, at $0.03.
AWH stock price history
Final trading statistics
- Final close
- $0.03
- Final trading day
- Apr 17, 2025
- Market cap at delisting
- $2.89M
- Shares outstanding
- 35.22M
- Final 52-week range
- $0.02 – $3.57
- Avg. volume (final 3 mo.)
- 4,591,607
- All-time high
- $5362.50 · Nov 2000
- All-time low
- $0.03 · Apr 2025
- Return since IPO
- -100.0%
- Beta
- 2.01
- Book value / share
- −$0.15
- Price / book
- -0.18
About Aspira Womens Health Inc
Aspira Women's Health, with its subsidiaries, developed and sold noninvasive, AI-powered diagnostic tests for gynecologic diseases in the U.S. Its Ova1Plus blood test assessed the chance of cancer in women with an ovarian adnexal mass. Overa was a biomarker test designed to keep Ova1's high sensitivity, and OvaWatch helped assess cancer risk in women with an indeterminate or benign mass.
In development were OvaMDx, which combined proteins, clinical data and miRNA to gauge ovarian cancer risk, plus EndoCheck for ovarian endometriomas and EndoMDx for endometriosis. Its Aspira Labs applied biomarker technology to gynecologic cancers and disease.
Customers included physicians and national and regional labs, reached through its sales force, the Aspira Synergy platform and a deal with BioReference Health. It had research ties with Dana-Farber Cancer Institute, Brigham and Women's Hospital and the Medical University of Lodz, and an alliance with Quest Diagnostics.
Formerly Vermillion, Inc., it became Aspira Women's Health in June 2020. It was incorporated in 1993 and based in Austin, Texas. Its stock was delisted from the Nasdaq in April 2025, with the last trade on April 17, 2025 at $0.03.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Austin, TX
- Employees
- 66
- IPO date
- June 27, 1996
- Delisted
- April 17, 2025
- SEC CIK
- 926617
Aspira Womens Health financials before the delisting
The last 5 fiscal years Aspira Womens Health reported as a public company, fiscal year ending December.
AWH revenue and net income
AWH earnings per share
AWH annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $9.18M | −$13.1M | −$1.00 |
| FY2023 | $9.15M | −$16.7M | −$12.01 |
| FY2022 | $8.18M | −$21.6M | −$0.27 |
| FY2021 | $6.81M | −$31.7M | −$0.28 |
| FY2020 | $4.65M | −$17.6M | −$0.18 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Aspira Womens Health stock FAQ
What happened to Aspira Womens Health stock?
Aspira Womens Health was delisted from the Nasdaq in April 2025. The final close was $0.03 on April 17, 2025.
Can I still buy AWH stock?
No. AWH is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on April 17, 2025.
What was the last price of AWH?
AWH last closed at $0.03 on April 17, 2025, which valued the company at about $2.89M.
How did Aspira Womens Health do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Aspira Womens Health reported revenue of $9.18M and net income of −$13.1M.
When did Aspira Womens Health go public?
Aspira Womens Health shares started trading on June 27, 1996.
AWH no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.